Sai Ma, PhD

Articles

July 18th 2019

Insurers’ Perspectives on MA Value-Based Insurance Design Model

Dmitry Khodyakov, PhD Christine Buttorff, PhD Kathryn Bouskill, PhD Courtney Armstrong, MPH Sai Ma, PhD Erin Audrey Taylor, PhD Christine Eibner, PhD

This article describes perspectives of Medicare Advantage (MA) insurers about participating in the CMS value-based insurance design model test launched in 2017.

January 15th 2008

All Things Considered, the Answer Is a Resounding Yes

Gordon K. Norman, MD, MBA. Author reply by Soeren Mattke, MD, DSc Michael Seid, PhD Sai Ma, PhD

December 1st 2007

Evidence for the Effect of Disease Management: Is $1 Billion a Year a Good Investment?

Soeren Mattke, MD, DSc Michael Seid, PhD Sai Ma, PhD

Latest Updated Articles

Opdivo packaging | Image credit: Bristol Myers Squibb

Published: May 9th 2024 | Updated: May 21st 2024

FDA Accepts Nivolumab Subcutaneous Injection Application, With Potential to Boost Access to PD-1 Inhibitors

Jason Porter, MD, an expert on lung cancer

Published: July 24th 2024 | Updated: July 27th 2024

Long-Term Follow-Up from CheckMate 9LA at ASCO 2024

Published: July 24th 2024 | Updated: July 27th 2024

Insights from the TROPION-Lung05 Trial at ASCO 2024

Liz Kwo, MD, MBA, MPH, chief commercial officer, Everly Health, and faculty lecturer, Harvard Medical School

Published: July 24th 2024 | Updated: July 27th 2024

Examining Trends, Future Directions in AI and Health Care

Aspirin tablets dissolving in water | Imaged credit: Victor Moussa - stock.adobe.com

Published: July 15th 2024 | Updated: July 27th 2024

No Sex Differences Identified in Aspirin Dosing for Secondary Prevention of ASCVD

Alfred L. Garfall, MD, an expert on multiple myeloma

Published: July 24th 2024 | Updated: July 27th 2024

Future Directions in the Management of Multiple Myeloma

2 Commerce Drive
Suite 100
Cranbury, NJ 08512

Do Not Sell My Information

Terms & Conditions